Crosstree Capital Partners Overview
- Service
- Financing Advisory
- Founded
- 2004
- Serviced Companies
- 93
- Serviced Deals
- 87
- Serviced Investors
- 14
Crosstree Capital Partners General Information
Description
Crosstree Capital Partners is a Tampa, Florida based healthcare-focused financing advisory firm. Founded in 2004, the firm work with companies involved in global research, development, and commercialization of biopharmaceutical, diagnostic and digital healthcare products and services. Crosstree specializes in advising clients on mergers and acquisitions, liquidations, divestitures, recapitalizations, add-on acquisitions and capital raising deals.
Contact Information
Website
Year Founded
2004
Service Provider Type
Financing Advisory
Primary Office
- 2701 North Rocky Point Drive
- Suite 925
- Tampa, FL 33607
- United States
+1 (813) 000-0000
Crosstree Capital Partners Services to Companies
Service on a Deal (87)
| Company Name | Service Provided | Deal Date | Deal Type | Deal Amount |
|---|---|---|---|---|
| WIRB-Copernicus Group | Advisor: General | Nov 2019 | 00000 | 0000000 |
| 000000000000 00000 | Advisor: General | Oct 2019 | 00000 | 0000000 |
| 000000 000000 | Advisor: General | Oct 2019 | 00000 | 0000000 |
| 00000000 0000000 | Advisor: General | Sep 2019 | 00000 | 0000000 |
| 0000000000 | Advisor: General | Jul 2019 | 00000 | 0000000 |
| 0000000 | Advisor: General | May 2019 | 00000 | 0000000 |
| 00000000000 | Advisor: General | Feb 2019 | 00000 | 0000000 |
| 00000000000 | Advisor: General | Feb 2019 | 00000 | 0000000 |
| Velos | Advisor: General | Dec 2018 | 00000 | 0000000 |
| Biorasi | Advisor: General | Nov 2018 | 00000 | 0000000 |
Crosstree Capital Partners Services to Investors
Service on a Deal — Buy Side (14)
| Investor Name | Service Provided | Deal Date | Deal Type | Deal Amount |
|---|---|---|---|---|
| MTBC. | Advisor: General | Jun 2020 | 00000 | 0000000 |
| 00000 | Advisor: Financial Due Diligence | Apr 2020 | 00000 | 0000000 |
| 000000 000000 | Advisor: General | Jun 2018 | 00000 | 0000000 |
| 00000000 | Advisor: General | Apr 2018 | 00000 | 0000000 |
| 0000000000 0000000 | Advisor: General | Jul 2015 | 00000 | 0000000 |
| 0000000000 | Advisor: General | Jul 2014 | 00000 | 0000000 |
| 000000 00000000000 | Advisor: General | Apr 2014 | 00000 | 0000000 |
| 00000 00000000000 | Advisor: General | Oct 2013 | 00000 | 0000000 |
| Plethico Pharmaceuticals | Advisor: General | Nov 2007 | 00000 | 0000000 |
| Palm Beach Capital | Advisor: General | Nov 2007 | 00000 | 0000000 |
Service on a Deal — Sell Side (7)
| Investor Name | Service Provided | Deal Date | Deal Type | Deal Amount |
|---|---|---|---|---|
| GlaxoSmithKline | Advisor: General | Nov 2018 | 00000 | 0000000 |
| 00000 00000 000000 | Advisor: General | Oct 2018 | 00000 | 0000000 |
| 000000 | Advisor: General | Oct 2018 | 00000 | 0000000 |
| 0000000000 0000000 | Advisor: General | Aug 2018 | 00000 | 0000000 |
| 0000000000 0000000 | Advisor: General | Nov 2012 | 00000 | 0000000 |
| Enthalpy Analytical | Advisor: General | Jun 2010 | 00000 | 0000000 |
| Medifacts International | Advisor: General | Mar 2007 | 00000 | 0000000 |
Crosstree Capital Partners Investment Preferences
| Preferred Industries | Preferred Verticals | Preferred Deal Types | Geographic Preferences | Transaction Amount |
|---|
This information is available in the PitchBook Platform. To explore Crosstree Capital Partners‘s full profile, request access.
Request a free trial